AdvaMed Innovation Agenda Aligns With Capitol Hill Objectives
This article was originally published in The Pink Sheet Daily
Executive Summary
A review of the medical device trade group's “Innovation Agenda” for the coming year and the recent 21st Century Cures proposal in Congress suggests a supportive environment for the association's priorities.
You may also be interested in...
Hamburg Warns Some Of Congress’ ‘Cures’ May Be ‘Dangerous’
Outgoing FDA Commissioner also cautions against unfunded mandates in Energy & Commerce’s biomedical reform proposal.
Hamburg Warns Some Of Congress’ ‘Cures’ May Be ‘Dangerous’
Outgoing FDA Commissioner also cautions against unfunded mandates in Energy & Commerce’s biomedical reform proposal.
IRB, HIPAA Changes To Be Folded Into 21st Century Cures Bill Next Year
Centralized institutional review board approvals for device trials, and removal of HIPAA privacy provisions that block registry data-sharing are among the ideas that are likely to make it into a draft bill planned for release in January as the next step in the House’s 21st Century Cures initiative.